Status:
COMPLETED
Usefulness of High-frequency QRS Analysis in the Evaluation of Patients With Chest Pain
Lead Sponsor:
Ori Galante
Collaborating Sponsors:
BSP Biological Signal Processing Ltd.
Conditions:
Acute Coronary Syndrome
STEMI
Eligibility:
All Genders
18+ years
Brief Summary
Accurate detection of a heart attack (an acute myocardial infarction) is one of the most pressing needs in medicine. Recordings of the electrocardiogram (ECG) (electrical activity of the heart) are on...
Detailed Description
Chest pain is one of the leading reasons for hospital emergency department (ED) visits worldwide. In the United States (US), over 6 million people annually undergo evaluation in the ED for acute chest...
Eligibility Criteria
Inclusion
- Patients with chest pain, suspected to have ACS
- Duration of chest pain greater than 20 minutes
- Time from onset of chest pain less than 12h
- Signed an informed consent
Exclusion
- History of trauma or any other evident medical cause of chest pain
- Prior coronary artery bypass graft
- Pre-excitation syndrome (example WPW)
- Atrial Fibrillation or significant ventricular arrhythmia
- Bundle branch block, intraventricular conduction delay or
- QRS duration greater than 120 ms
- Implanted pacemaker or defibrillator
- Patients who received fibrinolytic therapy, glycoprotein IIb or IIIa inhibitors before the initial ECG recording
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
324 Patients enrolled
Trial Details
Trial ID
NCT01185899
Start Date
August 1 2010
End Date
August 1 2013
Last Update
November 20 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Soroka University Medical Center
Beersheba, Israel, 84101